Dynavax Technologies Corporation (FRA:DYF1)
Germany · Delayed Price · Currency is EUR 13.25
+0.08 (0.61%)
At close: Jan 16, 2026
Dynavax Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 317.84 | 268.43 | 213.3 | 713.65 | 437.1 | 39.31 |
Other Revenue | 12.68 | 8.82 | 18.99 | 9.04 | 2.34 | 0.94 |
| 330.51 | 277.25 | 232.28 | 722.68 | 439.44 | 40.25 | |
Revenue Growth (YoY) | 26.73% | 19.36% | -67.86% | 64.45% | 991.75% | 14.29% |
Cost of Revenue | 126.91 | 108.26 | 102.48 | 308.75 | 205.8 | 40.02 |
Gross Profit | 203.6 | 168.99 | 129.81 | 413.93 | 233.64 | 0.23 |
Selling, General & Admin | 173.31 | 168.1 | 147.94 | 123.72 | 92.42 | 71.55 |
Amortization of Goodwill & Intangibles | - | - | - | - | - | 2.5 |
Operating Expenses | 184.28 | 168.1 | 160.26 | 123.72 | 92.42 | 74.05 |
Operating Income | 19.32 | 0.89 | -30.45 | 290.21 | 141.22 | -73.82 |
Interest Expense | -6.68 | -6.79 | -6.76 | -6.73 | -11.18 | -19.06 |
Interest & Investment Income | 29.54 | 36.46 | 31.99 | 7.91 | 0.14 | 1.26 |
Currency Exchange Gain (Loss) | 0.3 | 0.3 | -0.1 | 0.1 | 0.9 | -0.8 |
Other Non Operating Income (Expenses) | -1 | -0.01 | -0.05 | 1.81 | -49.33 | 3.93 |
EBT Excluding Unusual Items | 41.48 | 30.86 | -5.37 | 293.3 | 81.75 | -88.49 |
Gain (Loss) on Sale of Assets | - | - | 1 | 1 | 1 | 6.95 |
Other Unusual Items | -82.1 | - | - | - | -5.23 | 6.3 |
Pretax Income | -40.61 | 30.86 | -4.37 | 294.3 | 77.52 | -75.24 |
Income Tax Expense | 2.79 | 3.55 | 2.02 | 1.14 | 0.81 | - |
Net Income | -43.4 | 27.31 | -6.39 | 293.16 | 76.71 | -75.24 |
Preferred Dividends & Other Adjustments | - | - | - | 0.28 | 4.57 | - |
Net Income to Common | -43.4 | 27.31 | -6.39 | 292.87 | 72.14 | -75.24 |
Net Income Growth | - | - | - | 282.15% | - | - |
Shares Outstanding (Basic) | 122 | 130 | 129 | 126 | 116 | 101 |
Shares Outstanding (Diluted) | 122 | 133 | 129 | 151 | 133 | 102 |
Shares Change (YoY) | -7.72% | 3.58% | -14.63% | 13.38% | 31.04% | 40.93% |
EPS (Basic) | -0.35 | 0.21 | -0.05 | 2.32 | 0.62 | -0.75 |
EPS (Diluted) | -0.36 | 0.20 | -0.05 | 1.97 | 0.57 | -0.78 |
EPS Growth | - | - | - | 245.39% | - | - |
Free Cash Flow | 80.54 | 60.16 | 96.46 | 55.58 | 326.05 | -96.32 |
Free Cash Flow Per Share | 0.66 | 0.45 | 0.75 | 0.37 | 2.45 | -0.95 |
Gross Margin | 61.60% | 60.95% | 55.88% | 57.28% | 53.17% | 0.58% |
Operating Margin | 5.85% | 0.32% | -13.11% | 40.16% | 32.14% | -183.39% |
Profit Margin | -13.13% | 9.85% | -2.75% | 40.53% | 16.42% | -186.93% |
Free Cash Flow Margin | 24.37% | 21.70% | 41.53% | 7.69% | 74.20% | -239.31% |
EBITDA | 24.21 | 5.52 | -26.11 | 294.02 | 145.52 | -67.04 |
EBITDA Margin | 7.32% | 1.99% | -11.24% | 40.68% | 33.11% | -166.56% |
D&A For EBITDA | 4.89 | 4.63 | 4.34 | 3.81 | 4.3 | 6.77 |
EBIT | 19.32 | 0.89 | -30.45 | 290.21 | 141.22 | -73.82 |
EBIT Margin | 5.85% | 0.32% | -13.11% | 40.16% | 32.14% | -183.39% |
Effective Tax Rate | - | 11.49% | - | 0.39% | 1.04% | - |
Revenue as Reported | 330.51 | 277.25 | 232.28 | 722.68 | 439.44 | 46.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.